Ocugen, a clinical-stage biopharmaceutical company, announced the appointment of Jessica Crespo as chief accounting officer and senior vice president, finance.
In this role, she will be responsible for the development and execution of the company’s financial strategy, as well as all corporate finance, accounting, and internal and external financial reporting functions. She will serve as a member of the management team, reporting directly to the chief executive officer.
Crespo has more than 20 years of experience in accounting and financial leadership. She has been with Ocugen since 2019, previously serving as vice president, corporate controller and treasurer.
Before joining the company, she held financial leadership roles within Aerie Pharmaceuticals, Aralez Pharmaceuticals, and Cubist Pharmaceuticals, where she was responsible for financial and technical accounting and SEC reporting, including the implementation of new accounting standards and the accounting and reporting of complex transactions.
Prior to that, Crespo was a senior manager in Ernst & Young’s audit and assurance practice. She is a certified public accountant.